SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001504167-19-000013
Filing Date
2019-04-26
Accepted
2019-04-26 16:05:44
Documents
4
Period of Report
2019-04-26
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bpmx-20190426x8k.htm 8-K 42279
2 EX-3.1 bpmx-20190426ex310aaf298.htm EX-3.1 10366
3 EX-3.2 bpmx-20190426ex3267f4f9d.htm EX-3.2 140419
4 EX-99.1 bpmx-20190426ex9918098ce.htm EX-99.1 9931
  Complete submission text file 0001504167-19-000013.txt   204214
Mailing Address 1505 ADAMS DRIVE, SUITE D MENLO PARK CA 94025
Business Address 1505 ADAMS DRIVE, SUITE D MENLO PARK CA 94025 650-889-5020
BioPharmX Corp (Filer) CIK: 0001504167 (see all company filings)

IRS No.: 593843182 | State of Incorp.: DE | Fiscal Year End: 0131
Type: 8-K | Act: 34 | File No.: 001-37411 | Film No.: 19771758
SIC: 2834 Pharmaceutical Preparations